Skip to main content
Log in

Aktuelle Gesichtspunkte zur Auswertung der Bestimmung von Faktor VIII-Aktivität, Faktor VIII-assoziiertem Protein und Faktor VIII-neutralisierendem Antikörper

Current aspects on evaluation of assays of factor-VIII activity, factor-VIII associated protein and factor-VIII neutralizing antibody

  • Originalarbeiten
  • Published:
Blut Aims and scope Submit manuscript

Summary

In evaluating factor-VIII activity it should be noted that regarding the remaining activity of deficient plasma a linear reference curve is achieved. In the standard population factor-VIII activity and factor-VIII associated protein are distributed approximately lognormally. Due to this distribution certain results have been gained for the optimal choice of localisation and dispersion measures. It is assumed that the proportions of neutralized factor-VIII activity in plasma are distributed according to Poisson. The applicability of the Poisson distribution was also proved for the free factor-VIII activity portion. Due to the Poisson distribution the antibody unit is clearly defined, thus eliminating a further discussion on the establishment of an arbitrary standardized antibody unit.

Zusammenfassung

Bei der Bestimmung der Faktor VIII-Aktivität sollte beachtet werden, daß durch Berücksichtigung der Restaktivität des Mangelplasmas eine Linearisierung der Bezugskurve erreicht wird. Faktor VIII-Aktivität und Faktor VIII-assoziiertes Protein sind in der Normalpopulation annähernd lognormal verteilt. Aus dieser Verteilung ergeben sich für die Wahl der besten Lokalisations- und Dispersionsmaße Konsequenzen. Es wird angenommen, daß die Anteile der neutralisierten Faktor VIII-Aktivität im Plasma poissonverteilt sind. Für den Anteil der freien Faktor VIII-Aktivität konnte die Anwendbarkeit der Poisson-Verteilung nachgewiesen werden. Durch die Poisson-Verteilung ist die Antikörpereinheit eindeutig definiert. Hierdurch würde sich die weitere Diskussion über die Festsetzung einer arbiträren einheitlichen Antikörpereinheit erübrigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Bangham, D. R., Brozovič, M.: Factor VIII international units and reference materials. Thrombos. Diathes. haemorrh. (Stuttg.)31, 3 (1974)

    Google Scholar 

  2. Biggs, R.: Human blood coagulation, haemostasis and thrombosis, S. 614. Oxford: Blackwell 1972

    Google Scholar 

  3. Biggs, R.: The absorption of human factor VIII neutralizing antibody by factor VIII. Brit. J. Haemat.26, 259 (1974)

    Google Scholar 

  4. Biggs, R., Bidwell, E.: A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Brit. J. Haemat.5, 379 (1959)

    Google Scholar 

  5. Biggs, R., Austen, D. E. G., Denson, K. W. E., Rizza, C. R., Borrett, R.: The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs. Brit. J. Haemat.23, 125 (1972)

    Google Scholar 

  6. Biggs, R., Austen, D. E. G., Denson, K. W. E., Borrett, R., Rizza, C. R.: The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs. Brit. J. Haemat.23, 137 (1972)

    Google Scholar 

  7. Cann, J. R.: A phenomenological theory of rocket immunoelectrophoresis. Biophys. Chem.3, 206 (1975)

    Google Scholar 

  8. Denson, K. W. E.: Standardisation of methods for the determination of antihaemophilic factors. In: Proceedings of the VIth Congress of the World Federation of Haemophilia, S. 82, Baden, Vienna, 1970

    Google Scholar 

  9. Denson, K. W. E., Biggs, R.: Laboratory diagnosis, tests of clotting function and their standardisation. In: Human blood coagulation, haemostasis and thrombosis. Bigg, R. (ed.), S. 295. Oxford: Blackwell 1972

    Google Scholar 

  10. Egeberg, O.: Assay of antihemophilic A, B and C factors by one-stage cephalin systems. Scand. J. Clin. Lab. Invest.13, 140 (1961)

    Google Scholar 

  11. Girolami, A., Sticchi, A., Barbui, T., Bareggi, G.: Factor VIII immunological assay. An evaluation of several methods using whole plasma. Blut29, 309 (1974)

    Google Scholar 

  12. Hardisty, R. M., Macpherson, J. C.: A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. With a note on the calculation of confidence limits by G.I.C. Ingram. Thrombos. Diathes. haemorrh. (Stuttg.)7, 215 (1962)

    Google Scholar 

  13. Holmberg, L., Nilsson, I. M.: Immunologic studies in haemophilia A. Scand. J. Haemat.10, 12 (1973)

    Google Scholar 

  14. Hoyer, L. W.: Immunologic studies of antihemophilic factor (AHF, factor VIII). III. Comparative binding properties of human and rabbit anti-AHF. Blood39, 481 (1972)

    Google Scholar 

  15. Jeremic, M., Weisert, O., Gedde-Dahl, T.W.: Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand. J. clin. Lab. Invest.36, 461 (1976)

    Google Scholar 

  16. Kasper, C. K. et al.: A more uniform measurement of factor VIII inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.)34, 869 (1975)

    Google Scholar 

  17. Kasper, C. K., Pool, J. G.: Measurement of mild factor VIII inhibitors in Bethesda units. Thrombos. Diathes. haemorrh. (Stuttg.)34, 875 (1975)

    Google Scholar 

  18. Koutts, J., Meyer, D., Rickard, K., Stott, L., Firkin, B. G.: Heterogeneity in biological activity of human factor VIII antibodies. Brit. J. Haemat.29, 99 (1975)

    Google Scholar 

  19. Langdell, R. D., Wagner, R. H., Brinkhous, K. M.: Effect of antihemophilic factor on onestage clotting tests. J. Lab. Clin. Med.41, 637 (1953)

    Google Scholar 

  20. Laurell, C. B.: Electroimmuno assay. Scand. J. clin. Lab. Invest.29, Suppl. 124, 21 (1972)

    Google Scholar 

  21. Lechner, K.: Inactive factor VIII in hemophilia A and Willebrand's disease. A study of 117 cases. Acta Haemat.48, 257 (1972)

    Google Scholar 

  22. Moser, S., Pflugshaupt, R.: Vergleichende Untersuchungen über die Bestimmung der Faktor VIII-Aktivität. Schweiz. med. Wschr.104, 1372 (1974)

    Google Scholar 

  23. Penick, G. D., Roberts, H. R., McMillan, C. W.: Assays for antihemophilic factor (factor VIII). In: Thrombosis and bleeding disorders. Bang, N. U., Beller, F. K., Deutsch, E., Mammen, E. F. (eds.), S. 189. Stuttgart: Thieme; New York, London: Academic Press 1971

    Google Scholar 

  24. Pool, J. G., Miller, R. G.: Assay of the immun inhibitor in classic haemophilia: application of virus-antibody reaction kinetics. Brit. J. Haemat.22, 517 (1972)

    Google Scholar 

  25. Preston, A. E.: The factor VIII-activity in fresh and stored plasma. Brit. J. Haemat.13, 42 (1976)

    Google Scholar 

  26. Preston, A. E., Barr, A.: The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Brit. J. Haemat.10, 238 (1964)

    Google Scholar 

  27. Rizza, C. R., Biggs, R.: The treatment of patients who have factor VIII antibodies. Brit. J. Haemat.24, 65 (1973)

    Google Scholar 

  28. Sachs, L.: Statistische Auswertungsmethoden. Berlin, Heidelberg, New York: Springer 1972

    Google Scholar 

  29. Sell, E. A., Corrigan, J. J., Jr.: Platelet counts, fibrinogen concentrations, and factor V and factor VIII levels in healthy infants according to gestational age. Ariz. J. Pediat.82, 1028 (1973)

    Google Scholar 

  30. Shapiro, S. S.: The immunological character of acquired inhibitors of antihemophilic globulin (factor VIII) and the kinetics of their interaction with factor VIII. J. Clin. Invest.46, 147 (1967)

    Google Scholar 

  31. Veltkamp, J. J., Muller, A. D., Loeliger, E. A.: Indication, assay procedures, diagnosis, and advice. In: Human blood coagulation. Hemker, H.C., Loeliger, E.A., Veltkamp, J.J. (eds.), S. 173. Leiden: Leiden University Press 1969

    Google Scholar 

  32. Zimmermann, T. S., Ratnoff, O. D., Powell, A. E.: Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease. J. Clin. Invest.50, 244 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hintz, G. Aktuelle Gesichtspunkte zur Auswertung der Bestimmung von Faktor VIII-Aktivität, Faktor VIII-assoziiertem Protein und Faktor VIII-neutralisierendem Antikörper. Blut 36, 95–107 (1978). https://doi.org/10.1007/BF00996836

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00996836

Key words

Schlüsselwörter

Navigation